Growth Metrics

Merck (MRK) Leases (2019 - 2024)

Historic Leases for Merck (MRK) over the last 6 years, with Q4 2024 value amounting to $1.4 billion.

  • Merck's Leases fell 466.25% to $1.4 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 billion, marking a year-over-year decrease of 466.25%. This contributed to the annual value of $1.4 billion for FY2024, which is 466.25% down from last year.
  • Latest data reveals that Merck reported Leases of $1.4 billion as of Q4 2024, which was down 466.25% from $1.4 billion recorded in Q4 2023.
  • In the past 5 years, Merck's Leases registered a high of $1.7 billion during Q4 2020, and its lowest value of $1.3 billion during Q4 2022.
  • Its 5-year average for Leases is $1.5 billion, with a median of $1.4 billion in 2023.
  • Its Leases has fluctuated over the past 5 years, first soared by 5731.59% in 2020, then crashed by 1513.24% in 2022.
  • Over the past 5 years, Merck's Leases (Quarter) stood at $1.7 billion in 2020, then fell by 6.04% to $1.6 billion in 2021, then fell by 15.13% to $1.3 billion in 2022, then grew by 6.76% to $1.4 billion in 2023, then fell by 4.66% to $1.4 billion in 2024.
  • Its Leases stands at $1.4 billion for Q4 2024, versus $1.4 billion for Q4 2023 and $1.3 billion for Q4 2022.